Treatment of melancholia with tranylcypromine
- 1 February 1984
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 141 (2) , 288-289
- https://doi.org/10.1176/ajp.141.2.288
Abstract
Nine of 12 outpatients meeting DSM-III criteria for melancholia responded to treatment with the monoamine oxidase inhibitor (MAOI) tranylcypromine. Responders were less depressed before treatment and after treatment than were nonresponders. MAOIs appear useful in treating endogenous depressions.This publication has 3 references indexed in Scilit:
- Monoamine Oxidase InhibitorsArchives of General Psychiatry, 1979
- Research Diagnostic CriteriaArchives of General Psychiatry, 1978
- A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety StatesArchives of General Psychiatry, 1976